SPORTS PHARMA A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About SPORTS PHARMA A/S
SPORTS PHARMA A/S (CVR number: 70090414) is a company from VEJLE. The company recorded a gross profit of 4200 kDKK in 2023. The operating profit was -1003.8 kDKK, while net earnings were -1355.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -3.3 %, which can be considered poor and Return on Equity (ROE) was -37 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 20.8 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. SPORTS PHARMA A/S's liquidity measured by quick ratio was 0.5 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 5 152.18 | 6 255.91 | 4 980.04 | 5 096.56 | 4 199.97 |
EBIT | 595.12 | 579.51 | 156.76 | 761.14 | -1 003.81 |
Net earnings | 119.53 | 315.39 | 16.24 | 502.80 | -1 355.42 |
Shareholders equity total | 4 141.68 | 3 819.07 | 3 835.30 | 4 338.10 | 2 982.69 |
Balance sheet total (assets) | 15 046.80 | 15 440.19 | 18 349.66 | 18 583.68 | 18 109.58 |
Net debt | 5 330.70 | 4 460.22 | 8 081.62 | 8 193.96 | 8 230.16 |
Profitability | |||||
EBIT-% | |||||
ROA | 4.5 % | 4.9 % | 1.9 % | 6.2 % | -3.3 % |
ROE | 2.9 % | 7.9 % | 0.4 % | 12.3 % | -37.0 % |
ROI | 7.0 % | 7.9 % | 3.0 % | 9.0 % | -4.9 % |
Economic value added (EVA) | 263.17 | 216.44 | -76.81 | 358.64 | -1 055.56 |
Solvency | |||||
Equity ratio | 32.8 % | 29.9 % | 25.2 % | 27.6 % | 20.8 % |
Gearing | 129.9 % | 118.8 % | 216.2 % | 192.9 % | 282.1 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.6 | 0.5 | 0.6 | 0.6 | 0.5 |
Current ratio | 1.5 | 1.5 | 1.4 | 1.5 | 1.3 |
Cash and cash equivalents | 50.42 | 75.52 | 210.91 | 173.33 | 184.40 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.